Bowman & CO S.C. Edwards Lifesciences Corp Transaction History

Bowman & CO S.C.

$187 Million
Q3 2024

A detailed history of Bowman & CO S.C. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bowman & CO S.C. holds 12,339 shares of EW stock, worth $869,652. This represents 0.44% of its overall portfolio holdings.

Number of Shares

12,339

Previous 10,927 12.92%

Holding current value

$869,652

Previous $1.01 Million 19.33%

% of portfolio

0.44%

Previous 0.59%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$59.7 - $93.78 $84,296 - $132,417	1,412 Added 12.92%	12,339 $814,000
Q2 2024 Jul 24, 2024	BUY	$84.3 - $94.31 $83,709 - $93,649	993 Added 10.0%	10,927 $1.01 Million
Q1 2024 Apr 15, 2024	SELL	$72.54 - $95.56 $23,357 - $30,770	-322 Reduced 3.14%	9,934 $949,000
Q4 2023 Jan 10, 2024	BUY	$61.71 - $77.76 $51,219 - $64,540	830 Added 8.81%	10,256 $782,000
Q3 2023 Oct 04, 2023	BUY	$69.28 - $93.38 $121,447 - $163,695	1,753 Added 22.85%	9,426 $653,000
Q2 2023 Jul 17, 2023	BUY	$81.41 - $94.33 $15,630 - $18,111	192 Added 2.57%	7,673 $723,000
Q1 2023 Apr 13, 2023	BUY	$74.26 - $84.51 $218,027 - $248,121	2,936 Added 64.6%	7,481 $618,000
Q4 2022 Jan 20, 2023	SELL	$68.3 - $87.44 $110,646 - $141,652	-1,620 Reduced 26.28%	4,545 $0
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $19,768 - $25,749	240 Added 4.05%	6,165 $509,000
Q2 2022 Jul 29, 2022	BUY	$86.5 - $128.27 $23,355 - $34,632	270 Added 4.77%	5,925 $563,000
Q1 2022 Apr 29, 2022	BUY	$101.96 - $128.34 $9,278 - $11,678	91 Added 1.64%	5,655 $666,000
Q4 2021 Jan 31, 2022	BUY	$106.37 - $130.68 $591,842 - $727,103	5,564 New	5,564 $722,000

Others Institutions Holding EW

# of Institutions

1,349

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowman & CO S.C., based on Form 13F filings with the SEC.

News

Stay updated on Bowman & CO S.C. with notifications on news.

Account